Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis (scientific article published on 02 December 2019)

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

Q33883502

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Q34041688

The International HapMap Project Web site

Q34206586

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

Q34288506

A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences

Q35925225

Prediction of breast cancer risk based on profiling with common genetic variants

Q36583004

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial

Q36599573

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer

Q37113165

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Q37179254

Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs

Q37541290

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes

Q37541989

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

Q37682697

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Q38939206

Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.

Q40137394

A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

Q40143114

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Q47561710

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.

Q48580401

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Q51003983

Novel Common Genetic Susceptibility Loci for Colorectal Cancer

Q56359054

Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement

Q57112937

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Q57305944

Cumulative association of five genetic variants with prostate cancer

Q80503113

NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection